Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Developing Tailored Delivery and Adherence Interventions for use of Long-Acting Biomedical HIV Prevention Strategies by Transgender Women
Interviews to learn about new ways to inject PrEP
Enrolling:Female Patients Only
Study Length:1 Days
Clinic Visits:1
Age Range:Between 18 and 99 years old
IRB Number:7703
U.S. Government ID:NCT03856580
Contact: Christine Rael, Ph.D.: 6467746967 /
Additional Study Information:

We want to make PrEP better for transgender women! Your input will help us to understand how to support transgender women who use a potential future HIV prevention product: injectable PrEP. In this study, we will show you short videos on potential different ways to inject PrEP and ask you to tell us about your likes and dislikes about each method. We will also ask for your input on a new smartphone app to support transgender women who decide to use injectable PrEP. This will take about 1 hour of your time. This study offers compensation.

Do You Qualify?
Were you assigned male at birth?YesNo
Do you currently identify as a woman, transgender woman, woman of transgender experience, or another gender?YesNo
During the last 3 months did you have sex with another person? Sex can be anal, vaginal, or oralYesNo
Do you currently have any silicone implants in your hip, buttock, or thigh area?YesNo
Have you ever tested HIV-positive?YesNo
Christine Rael, PhD
You may be eligible for this study

Place Holder

Who Can I Contact?
For more information, please contact:
Christine Rael, Ph.D.
Phone: 6467746967